Treating hyperglycaemia in diabetes with polyunsaturated fatty acid analogues

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Diabetes, characterised by elevated blood glucose, has a major impact on affected children, their families and the community. Our preliminary evidence suggests that a newly developed polyunsaturated fatty acid normalises blood glucose levels in an experimental diabetes model. This research will attempt to provide evidence that we have discovered a fat which has insulin like action and which may be taken orally once every 3-4 days to treat the elevated blood glucose.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2016

Funding Scheme: Project Grants

Funding Amount: $602,260.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Biochemistry and Cell Biology not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

diabetes | diabetes mellitus | fatty acids | hyperglycaemia | retinopathy